New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline

OBJECTIVE: To determine the safety and effectiveness of delamanid in combination with bedaquiline in children for the treatment of multidrug-resistant tuberculosis. MATERIALS-METHODS: In 2023-2024, 18 children aged 3 to 17 years with MDR-TB were treated. Mycobacterium tuberculosis (MBT) was detected...

Full description

Bibliographic Details

Published in:	Journal of Global Antimicrobial Resistance
Main Authors:	Ekaterina Sokolskaya, Nadezhda Klevno, Anastasiya Samoylova, Alexey Kazakov, Anastasiya Gaida
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	multidrug-resistant tuberculosis MDR-TB in children bedaquiline delamanid
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716524003588